Just days after the U.S. eased key sanctions on Myanmar, General Electric became the first American company to invest in the former pariah state.
Johnson & Johnson stockholders, trying to restore high standards, have reached a tentative settlement in their lawsuit against J&J's board and top executives for allegedly letting serious legal and manufacturing problems continue for years.
A slew of new low-cost generic drugs will reduce loads on patients and insurers, while drug companies will grow quickly in developing countries.
Mead Johnson and other makers of baby formula were accused of using vanillin, a common vanilla substitute, which is not allowed in products for infants.
The new label indicates that physicians can implant up to five of the anti-snoring devices even though the FDA has only approved three.
Pentobarbital, one of three drugs Texas used previously, is now in short supply after its Danish manufacturer said it would try to prevent its use in executions.
CEO Arun Sawhney said the company is aiming to regularly be first on the U.S. market with just-approved generic drugs.
Substantial legal requirements result in more complex functional specifications for the implant manufacturers: From the design - including the materials — through production, the complete process chain must be documented and validated. CNC-controlled high-tech machines support the prosthetics manufacturers, and permit high-quality products to be manufactured despite the continuing pressures of high cost.
Design and manufacturing engineers strive to develop high-quality devices in a budget-conscious manner, but some challenges can potentially prevent the device from going to market.
Bespoke Innovations uses 3D scanning to capture and accurately recreate to produce a custom form that changes the way the world views prosthetics.
No two disturbances are the same, and the increased complexity of these disturbances has proven to be catastrophic to the lifespan and reliability of medical equipment.
Prosecutors said the company illegally promoted two drugs for unapproved uses, and demanded it be monitored by the FDA for five years to ensure compliance.
The German-based company that specializes in industrial and medical gases said it is looking to get a bigger slice of the growing health care market.
Diabetes is a growing focus for drugmakers as more people are diagnosed with the disease, partly due to rising obesity levels.
AnC Bio, a South Korean company that manufactures artificial organs, will spend build a $50 million plant that could also lease out clean rooms to business from around the world.
The FDA will review Onyx and Bayer's application for the colorectal cancer drug candidate regorafenib in six months instead of the usual 10.
Most importantly, the bill extends the FDA's budget for reviewing new drugs and medical implants, but lawmakers have added dozens more provisions.
The Basel, Switzerland-based company says its closure of the site in Nutley, N.J., will consolidate R&D with operations in Switzerland and Germany.
Teva had accused rival companies of infringing on patents covering the drug's chemical composition, and will now be free from generic competition until 2014.
Implants made with metal stems and sockets have been recently favored over ceramic versions, but U.K. surgeons say they're falling faster than expected.
Roche Diagnostics Corp. says it plans to spend $300 million over the next decade on projects at its North American headquarters in Indianapolis.
The biopharmaceutical firm says it will establish its global headquarters in New Haven with $20 million in loan forgiveness based on successful job creation.
Medical device maker Hologic came a step closer to completing its $3.76 billion acquisition of diagnostic test maker Gen-Probe after it passed a regulatory bar.
A top British medical expert says faulty French-made breast implants do not pose any long-term health problems to women.